A DECREASED PLATELET-TO-LYMPHOCYTE RATIO IS ASSOCIATED WITH A LOW PLATELETCRIT IN PRE-DIABETES

EHA Library, Bongani Nkambule, 215917

INCREASED PLATELET RESPONSE TO ENDOGENOUS AGONISTS, IN PRE-DIABETIC C57BL/6 MICE

EHA Library, Zibusiso Mkandla, 215922

INVOLVEMENT OF LEUCOCYTE DERIVED EXTRACELLULAR VESICLES IN THE PROCOAGULANT STATE FOUND IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA-RELATED CONDITION

EHA Library, Adeline Wannez, 215921

HEMATOLOGICAL PHENOTYPES OF DIFFERENT ALPHA-THALASSAEMIA GENOTYPES CAUSING HYPOCHROMIC MICROCYTIC ANEMIA AT NEONATAL PERIOD

EHA Library, thidarat suksangpleng, 215920

LABORATORY CHARACTERIZATION OF PATIENTS WITH (SUSPECTED) INHERITED PLATELET DISORDERS: RESULTS FROM THE ‘THROMBOCYTOPATHY IN THE NETHERLANDS’ STUDY

EHA Library, Maaike Blaauwgeers, 215916

INSUFFICIENT RECEPTOR EDITING LEADS TO DEFECTIVE B CELL CENTRAL TOLERANCE IN PRIMARY IMMUNE THROMBOCYTOPENIA (ITP)

EHA Library, Zi Sheng, 215915

NATIONAL EARLY WARNING SCORE (NEWS), QUICK SEQUENTIAL (SEPSIS-RELATED) ORGAN FAILURE ASSESSMENT (QSOFA) AND MICROBIOLOGICAL EVALUATION IN FEBRILE NEUTROPENIA OF ACUTE MYELOID LEUKEMIA

EHA Library, Barbara Nicolino, 215896

TPL2 KINASE HAS A TUMOR SUPPRESSIVE ROLE IN MYC-INDUCED LYMPHOMAGENESIS

EHA Library, ELIAS STAGAKIS, 215914

EVALUATION OF CORRELATION BETWEEN EARLY IMMATURE T-ALL IMMUNOPHENOTYPE, ABSENCE OF BIALLELIC DELETION OF TCR-Γ AND MEF2C EXPRESSION

EHA Library, Jay SINGH, 215895

PROGNOSTIC VALUE OF IKZF1 DELETIONS ON THE UKALL14 TRIAL; SIGNIFICANT ROLE OF BCR-ABL1 STATUS

EHA Library, Rachel Mitchell, 215894

METABOLOMIC ANALYSIS REVEALS CEREBROSPINAL FLUID CREATINE AND XANTHINE CONCENTRATIONS AS POTENTIAL BIOMARKERS FOR CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Antony Cousins, 215893

CYCLIN D1-MEDIATED GENE EXPRESSION DYSREGULATION IMPACTS MANTLE CELL LYMPHOMA PATHOGENESIS

EHA Library, Silvia Beà Bobet, 215913

NEXT-GENERATION SEQUENCING ALTERNATIVES FOR THE DETECTION AND QUANTIFICATION OF MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA PATIENTS

EHA Library, Alejandro Medina-Herrera, 215912

AN ESSENTIAL ROLE OF LCK IN T-ALL CELL PROLIFERATION AND SURVIVAL

EHA Library, Yuzhe Shi, 215892

MICRORNA-142 IS AN ESSENTIAL REGULATOR OF B CELL DEVELOPMENT AND MALIGNANT TRANSFORMATION

EHA Library, Wei-Le Wang, 215891

HIGH RISK AGGRESSIVE B-CELL LYMPHOMAS IDENTIFIED BY FISH: A MULTICENTRIC RETROSPECTIVE STUDY FROM CENTERS OF THE FONDAZIONE ITALIANA LINFOMI

EHA Library, Maria Chiara Tisi, 215898

GAU-PED STUDY: UPDATE ON RESULTS AND LONG-TERM OUTCOME OF PATIENTS WITH GAUCHER DISEASE DIAGNOSED THROUGH A PAEDIATRIC ALGORITHM

EHA Library, William Morello, 215899

THE OXYGENSCAN: CONTINUOUS MEASUREMENT AND QUANTIFICATION OF SICKLING DURING DE- AND REOXYGENATION TO MONITOR DISEASE SEVERITY AND TREATMENT EFFECT IN SICKLE CELL DISEASE.

EHA Library, Minke Rab, 215918

ENHANCED BONE MARROW HOMING OF NATURAL KILLER CELLS FOLLOWING MRNA TRANSFECTION WITH GAIN-OF-FUNCTION CXCR4

EHA Library, Emily Levy, 215900

ALLOGENEIC STEM CELL TRANSPLANTATION OVERCOMES THE NEGATIVE PROGNOSTIC IMPACT OF ASXL1 MUTATIONS IN TRANSPLANT ELIGIBLE PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA.

EHA Library, Abhishek Mangaonkar, 215919

INTERLEUKIN-15-CULTURED DENDRITIC CELLS ENHANCE ANTI-TUMOR GAMMA DELTA T CELL FUNCTIONS THROUGH IL-15 SECRETION

EHA Library, Heleen Van Acker, 215901

PI3P MODULATES MEGAKARYOCYTE MATURATION AND PROPLATELET PRODUCTION IN VITRO

EHA Library, Ivana Bertović, 215902

NIVOLUMAB TREATMENT DISCONTINUATION IN RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY EXPERIENCE

EHA Library, Liudmila Fedorova, 215903

RELEVANCE OF PRE AND POST TRANSPLANT PET AND HASENCLEVER INDEX IN PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANT FOR HODGKIN LYMPHOMA

EHA Library, Siddharth Turkar, 215904

DETECTION OF MYD88 AND CXCR4 MUTATIONS IN CELL-FREE DNA OF PATIENTS WITH IGM MONOCLONAL GAMMOPATHIES

EHA Library, Tina Bagratuni, 215911

A REAL WORLD STUDY OF CLINICAL CHARACTERISTICS AND TREATMENT OUTCOME OF HODGKIN LYMPHOMA IN MALAYSIA: A SINGLE CENTER EXPERIENCE IN A RESOURCE LIMITED SETTING

EHA Library, Tze Shin Leong, 215905

INTESTINAL COLONIZATION BY MULTIDRUG-RESISTANT GRAM-NEGATIVE PATHOGENS IN HEMATOLOGICAL PATIENTS: REAPPRAISAL OF SELECTIVE ORAL DECONTAMINATION

EHA Library, Igor Stoma, 215906

A HIGH LEVEL OF GENOMIC COMPLEXITY CORRELATES WITH ADVANCED PLASMA CELL DIFFERENTIATION STAGES IN NEWLY DIAGNOSED MM PATIENTS

EHA Library, Marina Martello, 215910

WHOLE EXOME SEQUENCING OF SYSTEMIC LIGHT CHAIN (AL) AMYLOIDOSIS

EHA Library, Isabel Cuenca Navarro, 215909

EMERGING MICROBIAL RESISTANCE IN FEBRILE NEUTROPENIA- IS IT HIGH TIME TO EVALUATE QUALITY CONTROL MEASURES?

EHA Library, Nida Anwar, 215907

BONE MARROW FAILURE AND PREDISPOSITION TO LEUKEMIA IN GATA2 HAPLOINSUFFICIENT MICE

EHA Library, Julia Weiss, 215908

LENALIDOMIDE PLUS BENDAMUSTINE-RITUXIMAB DOES NOT OVERCOME THE ADVERSE IMPACT OF TP53 MUTATIONS IN MANTLE CELL LYMPHOMA

EHA Library, Christian Winther Eskelund, 215897

RITUXIMAB INDUCES A PRO-INFLAMMATORY MICROENVIRONMENT THAT INCREASES NOTCH1 SIGNALLING IN CHRONIC LYMPHOCYTIC LEUKAEMIA CELLS.

EHA Library, Jennifer Edelmann, 214555

RANDOMIZED COMPARISON OF 90 MG VERSUS 60 MG DAUNORUBICIN IN 7+3 STANDARD INDUCTION FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: RESULTS FROM THE SAL-DAUNODOUBLE TRIAL

EHA Library, Christoph Röllig, 214551

ANALYSIS OF ANTI-THROMBOPOIETIN RECEPTOR ANTIBODYIES IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA

EHA Library, Takashi Satoh, 214562

A PROSPECTIVE PHASE II STUDY OF DARATUMUMAB IN PREVIOUSLY-TREATED SYSTEMIC LIGHT- CHAIN (AL) AMYLOIDOSIS

EHA Library, Arnaud Jaccard, 214545

HEPCIDIN MIMETIC PTG-300 INDUCES DOSE-RELATED AND SUSTAINED REDUCTIONS IN SERUM IRON AND TRANSFERRIN SATURATION IN HEALTHY SUBJECTS

EHA Library, Richard Shames, 214566

MESENCHYMAL STROMAL CELLS PROTECT ACUTE LYMPHOBLASTIC LEUKAEMIA CELLS FROM CYTARABINE INDUCED APOPTOSIS BY TRANSFER OF MITOCHONDRIA VIA TUNNELLING NANOTUBES IN A TREATMENT RESISTANT NICHE MODEL

EHA Library, Richard Burt, 214611

UNEXPECTED PREVALENCES OF THE JAK2V617F AND CALR MUTATIONS IN THE GENERAL POPULATION

EHA Library, Sabrina Cordua, 214616

RAS PATHWAY HYPERACTIVATION IS ASSOCIATED WITH INFERIOR SURVIVAL IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Klaus Geissler, 214472

VERY LOW DOSE PROPHYLAXIS IN CHILDREN WITH HAEMOPHILIA A: A RURAL INDIAN EXPERIENCE

EHA Library, DIBYENDU DE, 215843

ALLOGENEIC STEM CELL TRANSPLANTATION FOR PERIPHERAL T-CELL LYMPHOMAS: A STUDY OF 284 PATIENTS FROM THE SOCIÉTÉ FRANCOPHONE DE GREFFE DE MOELLE ET DE THÉRAPIE CELLULAIRE.

EHA Library, Stéphanie Nguyen Quoc, 214471

MOXETUMOMAB PASUDOTOX IN HEAVILY PRETREATED PATIENTS WITH RELAPSED/REFRACTORY HAIRY CELL LEUKEMIA: RESULTS OF A PIVOTAL INTERNATIONAL STUDY

EHA Library, Francis Giles, 214465

IBRUTINIB DOES NOT SUPPRESS CLONAL EVOLUTION IN HIGH RISK CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Davide Rossi, 214554

PREDICTION OF LEUKEMIA FREE SURVIVAL FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION IN AML: A RISK SCORE DEVELOPED BY THE ALWP OF THE EBMT

EHA Library, Roni Shouval, 214557

COMPARED ANALYSIS OF MUTATIONAL LANDSCAPE IN PEDIATRIC AND ADULT PATIENT WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Wenbin An, 214558

EFFICACY OF VENETOCLAX MONOTHERAPY IN PATIENTS WITH RELAPSED, REFRACTORY MANTLE CELL LYMPHOMA POST BTK INHIBITION THERAPY.

EHA Library, Toby Eyre, 214548

CALRETICULIN DEL52 KNOCK-IN MICE DEVELOP A DOSE-DEPENDENT THROMBOCYTOSIS AND PROGRESSION TO MYELOFIBROSIS

EHA Library, Caroline Marty, 214560

GENOMIC LANDSCAPE OF ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Li-Xin Wu, 214610

A PHASE 1, OPEN-LABEL STUDY TO DETERMINE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF ESCALATING DOSES OF LJPC-401 (SYNTHETIC HUMAN HEPCIDIN) IN PATIENTS WITH IRON OVERLOAD

EHA Library, Vip Viprakasit, 214475

ATRA COULD CORRECT THE IMPAIRED PROPLATELET FORMATION CAUSED BY THE TUBULIN Β1 SINGLE NUCLEOTIDE POLYMORPHISM R307H IN CORTICOSTEROID-RESISTANT ITP PATIENTS

EHA Library, Chen-cong Wang, 214474

DECREASED INCIDENCE OF INFECTION, USE OF ANTIBACTERIALS AND DAYS IN HOSPITAL AFTER ADMINISTRATION OF CLT-008 MYELOID PROGENITOR CELLS TO SUBJECTS RECEIVING AML INDUCTION THERAPY: PHASE 2 STUDY RESULTS

EHA Library, Pinkal Desai, 214467

FINAL RESULTS OF A PHASE IB STUDY OF ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA.

EHA Library, Joseph Mikhael, 214463

PROSPECTIVE PHASE II STUDY OF VENETOCLAX (VEN) IN PATIENTS (PTS) WITH PREVIOUSLY TREATED WALDENSTROM MACROGLOBULINEMIA (WM)

EHA Library, Jorge Castillo, 214547

ONCE-WEEKLY VS TWICE-WEEKLY CARFILZOMIB DOSING PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS OF THE RANDOMIZED PHASE 3 STUDY A.R.R.O.W.

EHA Library, Maria Victoria Mateos, 214544

DEVELOPMENT OF A GALNAC SIRNA CONJUGATE TARGETING TMPRSS6 FOR THE TREATMENT OF IRON OVERLOAD DISORDERS, SUCH AS B-THALASSEMIA

EHA Library, Ute Schaeper, 214565

A HISTIDINE PATCH IN THE N-DOMAIN OF MUTANT CALRETICULIN IS REQUIRED FOR MPN PATHOGENESIS

EHA Library, Jeanne Rivera, 214497

CO-OCCURRENCE OF STAG2 AND RAS SIGNALING MUTATIONS DURING PROGRESSION FROM MDS TO SAML ANALYZED BY WHOLE-EXOME AND TARGETED-DEEP SEQUENCING

EHA Library, Marta Martín Izquierdo, 214496

EFFECTS OF BONE MARROW MESENCHYMAL CELLS FROM IMMUNE THROMBOCYTOPENIA PATIENTS ON THE BIOLOGICAL BEHAVIORS OF MEGAKARYOCYTES

EHA Library, Hua Zhong, 214473

KD025-208: A PHASE 2 OPEN-LABEL TRIAL OF KD025-208 FOR STEROID-DEPENDENT CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD)

EHA Library, Madan Jagasia, 214470

PHASE 1 FIRST-IN-HUMAN TRIAL OF AMV564, A BIVALENT BISPECIFIC (2×2) CD33/CD3 T-CELL ENGAGER, IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Peter Westervelt, 214466

SYK TARGETING AS A POTENTIAL THERAPEUTIC STRATEGY FOR HIGH RISK TEL-AML1 PATIENTS

EHA Library, Valentina Serafin, 214553

NLRP3 INFLAMMSOME ACTIVATION IN PBMCS CONTROLS THE T CELL RESPONSE IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA

EHA Library, Mingqiang Hua, 214617

MODELING HIGH RISK ACUTE LEUKEMIA WITH COMBINED T-CELL AND MYELOID PHENOTYPE CAUSED BY THE ETV6-NCOA2 FUSION GENE

EHA Library, Hila Fishman, 214609

LIVER IRON CONTENT DETERMINES HEPCIDIN LEVELS

EHA Library, Sandro Altamura, 214564

EZH2 AND RUNX1 MUTATIONS COLLABORATE TO INITIATE DISTINCT HEMATOLOGICAL MALIGNANCIES DEPENDING ON THE TARGET CELL

EHA Library, Christopher Booth, 214614

DELETION OF STAT2 INCREASES THROMBOCYTOSIS AND SURVIVAL IN A JAK2 V617F MOUSE MODEL OF MPN VIA A NON CELL-AUTONOMOUS MECHANISM.

EHA Library, Gaëlle Vertenoeil, 214559

GRAFT-VERSUS-LEUKEMIA EFFECTS IN SECONDARY ACUTE MYELOID LEUKEMIA: A RETROSPECTIVE STUDY FROM THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT

EHA Library, Frederic Baron, 214556

PANOBINOSTAT, DECITABINE, AND DONOR LYMPHOCYTE INFUSION POST ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: THE HOVON 116 STUDY IN NEWLY DIAGNOSED POOR-RISK AML PATIENTS

EHA Library, Jan Cornelissen, 214550

REGULATION OF HIF-1Α IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET

EHA Library, Marta Coscia, 214468

ACALABRUTINIB IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA

EHA Library, Roger Owen, 214464

MOR202 WITH LOW-DOSE DEXAMETHASONE (DEX) OR POMALIDOMIDE/DEX OR LENALIDOMIDE/DEX IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): A PHASE I/IIA, MULTICENTER, DOSE-ESCALATION STUDY

EHA Library, Marc Raab, 214462

A NOVEL INHIBITORY MUTATION FOR JAK2 V617F TARGETING THE AROMATIC INTERACTION AROUND F617 RESTORES NORMAL FUNCTION FOR MOST OF JAK2-UTILIZING CYTOKINE RECEPTORS EXCEPT IFNGR

EHA Library, Emilie Leroy, 214615

INTRINSIC DEFECTS CAUSED BY COMBINED CSNK1A1/RPS14 AND MIRNA145/146A DEFICIENCY DIRECTLY ALTER THE MICROENVIRONMENT IN A NOVEL MOUSE MODEL FOR DEL(5Q) MDS

EHA Library, Flavia Ribezzo, 214613

MULTIPLE MECHANISMS OF KRAS ACTIVATION IN TRISOMY 12 CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Elena Vendramini, 214612

A STRATEGY WITH CHAPERONE-LIKE COMPOUNDS TO RESTORE EXPRESSION OF FACTOR IX VARIANTS AFFECTED BY FREQUENT MISSENSE MUTATIONS CAUSING HEMOPHILIA B

EHA Library, Mirko Pinotti, 214561

PIGGYBAC TRANSPOSON SCREENING IDENTIFIES NOVEL CANCER GENES AND REGULATORY ELEMENTS IN T CELL LEUKEMIA

EHA Library, Anja Pfaus, 214552

PROSPECTIVE STUDY OF HLA-MATCHED DONOR AVAILABILITY AND SURVIVAL IN REMISSION AFTER AML IN OLDER ADULTS: 1ST PLANNED ANALYSIS FROM ECOG-ACRIN E2906 PHASE III RANDOMIZED TRIAL IN PATIENTS AGE ≥60 YEARS

EHA Library, James M Foran, 214549

MULTINATIONAL, RANDOMIZED PHASE 3 TRIAL OF IBRUTINIB-RITUXIMAB VS PLACEBO-RITUXIMAB IN PATIENTS WITH WALDENSTRÖM’S MACROGLOBULINEMIA.

EHA Library, Meletios Dimopoulos, 214546

ADMINISTRATION OF BPX-501 CELLS FOLLOWING ALPHA/BETA T-CELL AND B-CELL-DEPLETED HLA HAPLOIDENTICAL HSCT (HAPLO-HSCT) IN CHILDREN WITH PRIMARY IMMUNODEFICIENCIES

EHA Library, Daria Pagliara, 214469

OPTIMISMM: PHASE 3 TRIAL OF POMALIDOMIDE, BORTEZOMIB, AND LOW‐DOSE DEXAMETHASONE VS BORTEZOMIB AND LOW-DOSE DEXAMETHASONE IN LENALIDOMIDE-EXPOSED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Paul Richardson, 214461

INVESTIGATING THE ROLE OF NCOA4 IN ACUTE AND CHRONIC IRON RELEASE FROM STORES

EHA Library, Antonella Nai, 214563

Intensive chemotherapy regimens in acute myeloide leukemia

EHA Library, Je-Hwan Lee, 219196

Bispecific antibodies for ALL

EHA Library, C Peters, 219185

CART cells

EHA Library, Franco Locatelli, 219186

The imperative for change in adverse event reporting in hematologic malignancies

EHA Library, Gita Thanarajasingam, 219187

Using patient-reported outcomes to improve toxicity assessment

EHA Library, Fabio Efficace, 219188

Toxicity in hematologic malignancies: Considerations in bone marrow transplant, survivors and real world hematology patients

EHA Library, John Gribben, 219189

Time trends in incidence rates of venous thrombosis

EHA Library, Sigrid Braekkan, 219191

Future challenges in prevention and treatment of venous thrombosis

EHA Library, John-Bjarne Hansen, 219192

Non-intensive treatment strategies in AML

EHA Library, Gert Ossenkoppele, 219195

QUIZARTINIB SIGNIFICANTLY PROLONGS OVERALL SURVIVAL IN PATIENTS WITH FLT3-INTERNAL TANDEM DUPLICATION–MUTATED (MUT) RELAPSED/REFRACTORY AML IN THE PHASE 3, RANDOMIZED, CONTROLLED QUANTUM-R TRIAL

EHA Library, Jorge Cortes, 218882

Jean Bernard Lifetime Achievement Award: Lecture

EHA Library, Charlotte Niemeyer, 219180

José Carreras Award lecture: Research challenges and therapeutic perspectives in APL

EHA Library, Francesco Lo Coco, 219182

Autoimmunity checkpoints as therapeutic targets in B-cell malignancies

EHA Library, Markus MUSCHEN, 219183

RAS MUTATIONS ARE THE DOMINANT MECHANISM OF SECONDARY RESISTANCE TO GILTERITINIB THERAPY FOR RELAPSED/REFRACTORY FLT3-MUTATED AML

EHA Library, Christine M McMahon, 214486

A NOVEL BAEVRLESS-PSEUDOTYPED GLOBIN LENTIVIRAL VECTOR DRIVES HIGH AND STABLE FETAL HEMOGLOBIN EXPRESSION IMPROVING THALASSEMIC ERYTHROPOIESIS IN VITRO

EHA Library, Nicholas P Anagnou, 214460

RECENT PROGRESS IN GENE THERAPY FOR SEVERE SICKLE CELL DISEASE: UPDATED INTERIM RESULTS FROM A PHASE 1 CLINICAL STUDY OF LENTIGLOBIN GENE THERAPY

EHA Library, Julie Kanter, 214456

A PHASE 2 STUDY TO ASSESS THE SAFETY AND EFFICACY OF UMBRALISIB (TGR-1202) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WHO ARE INTOLERANT TO PRIOR BTK OR PI3K DELTA INHIBITOR THERAPY

EHA Library, Anthony R. Mato, MD, 214453

ATEZOLIZUMAB PLUS R-CHOP SHOWS ENCOURAGING ACTIVITY AND ACCEPTABLE TOXICITY IN PREVIOUSLY UNTREATED PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): AN INTERIM ANALYSIS OF A PHASE I/II STUDY

EHA Library, Anas Younes, 214450